Financial Year |
March 31 2023 |
Monetary Funds |
578,439,024.83 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
792,096,359.14 |
Accounts Receivable |
689,679,123.15 |
Advances to Suppliers |
87,195,606.63 |
Other Receivables |
1,942,985.78 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
719,888,554.90 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
30,227,595.94 |
Total Current Assets |
2,899,469,250.37 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
923,278,144.13 |
Under-construction Projects |
282,298,466.76 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
95,174,556.65 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
2,284,873.17 |
Deferred Income Tax Assets |
18,639,638.20 |
Other Non-Current Assets |
69,188,255.93 |
Sub-Total of Non-Current Assets |
1,529,397,448.75 |
Total Assets |
4,428,866,699.12 |
Short-Term Loans |
1,179,931,706.87 |
Trading Financial liabilities |
-- |
Notes Payable |
711,076,335.99 |
Accounts Payable |
505,263,512.50 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
6,439,119.36 |
Taxes Payable |
4,729,065.37 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
830,501.91 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
4,934,338.03 |
Other Current Liabilities |
6,880,307.52 |
Sub-Total of Current Liabilities |
2,421,086,807.72 |
Long-term Loans |
214,203,399.86 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
8,880,000.00 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
12,358,858.27 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
327,739,259.45 |
Total Liabilities |
2,748,826,067.17 |
Paid-In Capital(Or Share Stock) |
107,839,341.00 |
Capital Surplus |
1,019,272,835.93 |
Surplus Reserve |
5,664,684.94 |
LESS:Treasury Stock |
4,075,036.00 |
Undistributed Profits |
550,941,814.68 |
Minority Stockholder's Interest |
1,521,082.58 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,678,519,549.37 |
Owner's Equity(Stockholder's Equity) |
1,680,040,631.95 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
4,428,866,699.12 |